114 related articles for article (PubMed ID: 31278284)
1. Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.
Pandey NO; Chauhan AV; Raithatha NS; Patel PK; Khandelwal R; Desai AN; Choxi Y; Kapadia RS; Jain ND
Sci Rep; 2019 Jul; 9(1):9729. PubMed ID: 31278284
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 9 (TLR9) genetic variants rs187084 and rs352140 confer protection from Behcet's disease among Iranians.
Tadayon Z; Shahzadeh Fazeli SA; Gholijani N; Daryabor G
BMC Rheumatol; 2024 Mar; 8(1):13. PubMed ID: 38481344
[TBL] [Abstract][Full Text] [Related]
3. The association of telomere maintenance and TERT expression with susceptibility to human papillomavirus infection in cervical epithelium.
Wang LN; Wang L; Cheng G; Dai M; Yu Y; Teng G; Zhao J; Xu D
Cell Mol Life Sci; 2022 Jan; 79(2):110. PubMed ID: 35098380
[TBL] [Abstract][Full Text] [Related]
4. Relationship of Toll-Like Receptor 7, 9, and 10 Polymorphisms and the Severity of Coronavirus Disease 2019.
Bayyurt B; Baltacı S; Şahin NÖ; Arslan S; Bakır M
Jpn J Infect Dis; 2024 May; 77(3):161-168. PubMed ID: 38296538
[TBL] [Abstract][Full Text] [Related]
5. Impact of
Obrenović M; Šupić G; Miyabe S; Mladenović I; Kozomara R; Jović S; Petković Ćurčin A; Štefik D; Stosić S; Vukomanović Đurđević B
Biomol Biomed; 2024 Jun; ():. PubMed ID: 38850110
[TBL] [Abstract][Full Text] [Related]
6. TLR9 gene region polymorphisms and susceptibility to tuberculosis in Vietnam.
Graustein AD; Horne DJ; Arentz M; Bang ND; Chau TT; Thwaites GE; Caws M; Thuong NT; Dunstan SJ; Hawn TR
Tuberculosis (Edinb); 2015 Mar; 95(2):190-6. PubMed ID: 25616954
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in the ITPKC gene and cervical squamous cell carcinoma risk.
Yang YC; Chang TY; Chen TC; Chang SC; Chen WF; Chan HW; Lin WS; Wu FT; Lee YJ
Cancer Immunol Immunother; 2012 Nov; 61(11):2153-9. PubMed ID: 22610085
[TBL] [Abstract][Full Text] [Related]
8. Association between variations in the TLR4 gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol.
Kolz M; Baumert J; Müller M; Khuseyinova N; Klopp N; Thorand B; Meisinger C; Herder C; Koenig W; Illig T
BMC Med Genet; 2008 Feb; 9():9. PubMed ID: 18298826
[TBL] [Abstract][Full Text] [Related]
9. Association of TLR4 gene rs4986790 and rs4986791 polymorphisms with asthma susceptibility: meta-analysis and trial sequential analysis.
Guo N; Tian H; Song T; Peng Y
Ann Saudi Med; 2024; 44(3):183-194. PubMed ID: 38853478
[TBL] [Abstract][Full Text] [Related]
10. Association between toll-like receptors 9 (TLR9) gene polymorphism and risk of pulmonary tuberculosis: meta-analysis.
Chen Z; Wang W; Liang J; Wang J; Feng S; Zhang G
BMC Pulm Med; 2015 May; 15():57. PubMed ID: 25948535
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 9 polymorphisms are associated with severity variables in a cohort of meningococcal meningitis survivors.
Sanders MS; van Well GT; Ouburg S; Morré SA; van Furth AM
BMC Infect Dis; 2012 May; 12():112. PubMed ID: 22577991
[TBL] [Abstract][Full Text] [Related]
12. Genetic Association of Toll-Like Receptor 4 (TLR4) Gene Polymorphism (rs4986790) With Oral Squamous Cell Carcinoma (OSCC): A Pilot Case-Control Study.
Gautam B; Pandi A; Girija ASS; Arumugam P; Priyadharsini VJ
Cureus; 2024 Mar; 16(3):e56021. PubMed ID: 38606218
[TBL] [Abstract][Full Text] [Related]
13. TLR9 gene polymorphism confers risk to Helicobacter pylori infection in Jiangsu, China and its inspiration for precision nursing car.
Liang Y; Wang D
Technol Health Care; 2024 May; ():. PubMed ID: 38788101
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in immune mediators associate with risk of cervical cancer.
Zhang Z; Fye S; Borecki IB; Rader JS
Gynecol Oncol; 2014 Oct; 135(1):69-73. PubMed ID: 25127987
[TBL] [Abstract][Full Text] [Related]
15. The relationship between Toll-like receptor-4 genes and preeclampsia outcomes.
Kurmanova A; Urazbayeva G; Salimbayeva D; Terlikbayeva A; Kypshakbayeva Z; Smailov M
J Assist Reprod Genet; 2024 May; ():. PubMed ID: 38819715
[TBL] [Abstract][Full Text] [Related]
16. Association of TLR4 and TLR9 gene polymorphisms and haplotypes with cervicitis susceptibility.
Chauhan A; Pandey N; Desai A; Raithatha N; Patel P; Choxi Y; Kapadia R; Khandelwal R; Jain N
PLoS One; 2019; 14(7):e0220330. PubMed ID: 31365550
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India.
Nath N; Mishra P; Panda AK; Mishra R
Int Immunopharmacol; 2020 Nov; 88():106925. PubMed ID: 32871478
[TBL] [Abstract][Full Text] [Related]
18. Toll-Like Receptor 9 Agonists in Cancer.
Karapetyan L; Luke JJ; Davar D
Onco Targets Ther; 2020; 13():10039-10060. PubMed ID: 33116588
[TBL] [Abstract][Full Text] [Related]
19. TLR9 Mediated Tumor-Stroma Interactions in Human Papilloma Virus (HPV)-Positive Head and Neck Squamous Cell Carcinoma Up-Regulate PD-L1 and PD-L2.
Baruah P; Bullenkamp J; Wilson POG; Lee M; Kaski JC; Dumitriu IE
Front Immunol; 2019; 10():1644. PubMed ID: 31379843
[No Abstract] [Full Text] [Related]
20. Polymorphisms in Toll-like receptors genes changes the host's immune response and is associated with cervical cancer.
Moura EL; Santos IFD; Freitas PP; Silva DMD; Santos ACMD; Lira Neto AB; Silva ACPE; Barbosa NR; Nascimento CA; Balliano TL; Fraga CAC; Farias KF; Figueiredo EVMS
Immunobiology; 2022 Mar; 227(2):152187. PubMed ID: 35158151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
